Italy is one of Europe’s five largest spine markets, worth roughly USD 350 million in spinal implants alone, and home to a small but specialised group of local manufacturers. Most are based in northern Italy, several in the Mirandola biomedical district near Modena, and they compete on niches rather than breadth.
Market overview
The Italian spinal implant market grows slowly but steadily. MarketsandMarkets valued it at USD 352.4 million in 2023 and expects USD 420.3 million by 2028, a CAGR of 3.6%. Demographics are the main tailwind. Italy has the oldest population in the EU: people aged 65 and over were 24.7% of residents in 2025, and ISTAT expects that share to reach 34.5% by 2050. Degenerative disease, stenosis and osteoporotic vertebral fractures will keep procedure volumes rising.
Fusion volumes have already climbed fast. The Ministry of Health counted 30,735 spinal fusions in 2017, up 136% from about 13,000 in 2010, a jump that also opened a debate about appropriateness.
Multinationals hold most of the market. In 2023 we named Zimmer Biomet, Stryker, DePuy Synthes, Medtronic and Globus Medical as the companies with substantial shares. Since then, Zimmer Biomet’s former spine unit has become Highridge Medical and Stryker has sold its spine implant business to VB Spine.
What shapes the market
Regional tenders. The regions run healthcare, and most implants are bought through tenders managed by central purchasing bodies such as ARIA in Lombardy or Intercent-ER in Emilia-Romagna. Price weighs heavily and broad catalogues have an edge, so smaller Italian makers often sell through distributors or partner with larger groups.
Payback. No issue worries Italian medtech more. When a region exceeds its device spending cap, suppliers must refund part of the overspend in proportion to their sales. The Constitutional Court upheld the mechanism in 2024 but capped payments at 48%, and in 2025 the government cut the 2015-2018 bill to 25% for companies paying by 9 September.
The problem is still open. The 2027 Budget Bill would raise the device spending cap from 4.6% to 4.7% of health funding and add a state contribution of EUR 350 million a year from 2028 to 2031. Confindustria Dispositivi Medici estimates the total bill at EUR 12.5 billion for 2019-2029, with the first instalment due by 30 July 2027. Companies also pay 0.75% of turnover into a national governance fund.
Regulation. The EU Medical Device Regulation has raised the cost of keeping implants on the market, hitting small portfolios hardest.
The Mirandola district. Much of Italy’s local spine industry comes from one place: Mirandola, a small town north of Modena that has been a biomedical hub since the 1960s. Tsunami Medical and BPB Medica are based there and G21 is a few kilometres away. The district gives them suppliers for moulding, metalwork, cleanrooms and sterilisation within a short drive, which cuts costs and speeds up development. That is why so many Italian spine products are kits, disposables and cements, and why local firms often make products for foreign brands. It is also innovative: according to Intesa Sanpaolo, 36.2% of district firms file patents, against 15.4% for the Italian biomedical sector as a whole.
Italian manufacturers
The Italian spine industry is made up of small and mid-size specialists:
- Tsunami Medical: Tsunami is one of the most complete Italian spine implant company and the one with the strongest presence abroad. It started in 1997 as a subcontractor for large makers of invasive diagnostic devices and later bought Bloodline, a biopsy brand well known in South America, Europe and Russia. Since 2010 it has bet on additive manufacturing, and today it claims one of the widest ranges of 3D-printed spinal cages on the market, plus a 3D-printed screw and rod system. The catalogue covers static, expandable and stand-alone cages for cervical and lumbar approaches, pedicle screws, vertebroplasty and kyphoplasty. The plant near Modena has ISO 8 and ISO 5 cleanrooms and accepts OEM and private-label work.
- BPB Medica (Biopsybell): vertebroplasty and kyphoplasty kits, percutaneous discectomy, and biopsy needles; Mirandola.
- Clover Orthopedics: cervical and lumbar implants, interspinous devices and biologics; Milan.
- Diametros Medical: the Lobster Project 2.0 percutaneous interspinous spacer.
- G21: bone cements for vertebroplasty and kyphoplasty; San Possidonio.
- Lincotek: contract and additive manufacturing for implant OEMs; Parma and Trento.
- Sintea Plustek: spine and orthopaedic devices; Italian activity unconfirmed.
- Techlamed: laser decompression and percutaneous interspinous fusion.
- Tecres: PMMA cements, including Mendec Spine; Sommacampagna.
Their strength lies in niches an ageing country needs most: additive manufacturing, cements and vertebral augmentation, and percutaneous solutions. With the payback bill due from July 2027, expect more OEM deals, FDA filings and foreign partnerships.
###
Legal Disclaimer:
Content published on SPINEMarketGroup (thespinemarketgroup.com) is provided for informational purposes only and on an “as is” basis, without warranties of any kind. We do not guarantee the accuracy, completeness, legality, or reliability of any information, images, videos, links, or third-party materials featured on the site. Any views or claims expressed in contributed content or press releases belong to their respective authors or sources. For copyright concerns, factual corrections, or content-related complaints, please contact us directly for review.